Healthcare resource utilization and costs after initiating direct-acting oral anticoagulants or low molecular weight heparins in patients with venous thromboembolism

Venous thromboembolism (VTE) can lead to significant healthcare resource utilization (HcRU) and costs. First-line treatments such as direct-acting oral anticoagulants (DOAC) and low molecular weight heparin (LMWH) are utilized for VTE management. There are limited observational studies to determine...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Vascular medicine (London, England) Ročník 30; číslo 2; s. 197
Hlavní autori:	Okoye, Godwin, Ben-Umeh, Kenechukwu C, Avanceña, Anton Lv, Onukwugha, Eberechukwu
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	England 01.04.2025
Predmet:	Administration, Oral Adult Aged Anticoagulants - administration & dosage Anticoagulants - adverse effects Anticoagulants - economics Cost Savings Cost-Benefit Analysis Databases, Factual Drug Costs Factor Xa Inhibitors - administration & dosage Factor Xa Inhibitors - adverse effects Factor Xa Inhibitors - economics Female Health Care Costs Health Resources - economics Heparin, Low-Molecular-Weight - administration & dosage Heparin, Low-Molecular-Weight - adverse effects Heparin, Low-Molecular-Weight - economics Humans Male Middle Aged Patient Acceptance of Health Care Retrospective Studies Time Factors Treatment Outcome United States Venous Thromboembolism - diagnosis Venous Thromboembolism - drug therapy Venous Thromboembolism - economics United States low molecular weight heparin Direct oral anticoagulant (DOAC) healthcare cost venous thromboembolism (VTE) healthcare use
ISSN:	1477-0377, 1477-0377
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!